WebMar 3, 2024 · MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) and Incyte Corporation (NASDAQ: INCY) announced today that their joint collaboration and license agreement for the further development and global commercialization of MorphoSys' investigational compound tafasitamab (MOR208) has … WebApr 15, 2024 · International Biotechnology Trust PLC lowered its stake in Incyte Co. ( NASDAQ:INCY - Get Rating) by 20.8% in the 4th quarter, according to its most recent filing …
INCY Incyte Corp. SEC Filings MarketWatch
WebFeb 23, 2011 · Incyte Corp (INCY) SEC Filing 10-K Annual report for the fiscal year ending Friday, December 31, 2010. Home. SEC Filings. Incyte Corp (INCY) 10-K Annual Report Wed Feb 23 2011; ... Incyte Corporation (Nasdaq:INCY) today reported fourth quarter and full year 2010 financial results, provided 2011 key objectives, and announced its 2011 financial ... WebApr 11, 2024 · Exchange Traded Concepts LLC decreased its position in Incyte Co. (NASDAQ:INCY - Get Rating) by 7.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 25,291 shares of the biopharmaceutical company's stock after selling 2,039 shares during the q cscwarehousing cbp.dhs.gov
Sumitomo Mitsui Trust Holdings Inc. Sells 32,657 Shares of Incyte …
WebApr 6, 2024 · Latest SEC filings for Incyte Corporation (INCY). If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. WebOct 13, 2015 · WILMINGTON, Del. and KENILWORTH, N.J. — Incyte Corporation (Nasdaq: INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the expansion of the companies’ ongoing clinical collaboration to include a Phase 3 study evaluating the combination of epacadostat, Incyte’s investigational … WebFeb 8, 2024 · The SEC alleges that Panuwat knew, or was reckless in not knowing, that the information about Medivation’s imminent acquisition at a significant premium was … dyson director salary